FGF21 and neoplasm: Our initial findings revealed reduced FGF21 expression in PDAC tissues, which correlated with advanced tumor stage, lymph node metastasis, vascular invasion, and poor prognosis, implicating FGF21 loss in PDAC aggressiveness.